Month: February 2021

Dallas, Feb. 02, 2021 (GLOBE NEWSWIRE) — Thryv Holdings, Inc. (NASDAQ:THRY), provider of Thryv® software, the leading end-to-end customer experience platform built for small business, announced today it has partnered with franchise-focused growth equity firm Franworth® to support emerging franchise brands. Thryv already serves more than 40,000 small to medium sized businesses (SMBs) through its cloud-based software and, working with Franworth, will extend its offering to help new franchise systems compete with established brands and reach more customers, stay organized, get paid faster, and generate reviews.    “Franchise brands are an important piece of the small business ecosystem. We recognize there are up-and-coming franchisors in search of quality resources and guidance to help their brands grow and excel,” said Matthew Gourgeot,...

NEW YORK and CLEVELAND, Feb. 02, 2021 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that it will host a live webinar for the investment community on Tuesday, February 16, 2021 at 1:00 p.m. EST to review clinical data on the company’s investigational AAV-based gene therapies ABO-102 and ABO-101 presented at the 17th Annual WORLDSymposium™.Speakers will include Kevin Flanigan, M.D., Director, Center for Gene Therapy at AWRI at Nationwide Children’s and Transpher A study principal investigator, Maria Jose de Castro, M.D., Hospital Clínico Universitario Santiago de Compostela and Transpher B study investigator, and Michael Amoroso, Principal Executive and Chief Operating Officer of Abeona.To register in advance for the live webinar, please visit...

VANCOUVER, British Columbia, Feb. 02, 2021 (GLOBE NEWSWIRE) — Serengeti Resources Inc. (SIR: TSX-V) (“Serengeti” or “the Company”) is pleased to report the final batch of assay results from the 2020 drilling campaign completed at the Kwanika Project in north-central BC. A total of 4,350 metres were drilled in 9 holes testing a number of exploration targets and resource expansion opportunities. The first batch of results were reported on December 16th, 2020. The advanced resource-stage Kwanika project is ~26,000 hectares, held by Kwanika Copper Corporation (KCC)*, and is located in the Quesnel Trough of British Columbia which hosts numerous porphyry copper-gold deposits.“The 2020 drilling program at Kwanika was a success. K-202 from the current release, combined with previously released K-197, demonstrates...

FDA removes clinical hold for pivotal Phase 2 MB-107 clinical trialCompany plans to enroll first patient in MB-107 pivotal trial in the second quarter of 2021Clinical outcomes in investigator-IND XSCID trials continue to show compelling efficacyWORCESTER, Mass., Feb. 02, 2021 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today provided updates on MB-107 and MB-207, its lentiviral gene therapies for the treatment of X-linked severe combined immunodeficiency (“XSCID”), also known as bubble boy disease. On January 28, 2021, the U.S. Food and Drug Administration (“FDA”) removed the clinical hold on the MB-107...

SAN ANTONIO, Feb. 02, 2021 (GLOBE NEWSWIRE) — Rackspace Technology™ (NASDAQ: RXT) today announced that its wholly owned subsidiary Rackspace Technology Global, Inc. (the “Company”) is proposing to issue $550.0 million aggregate principal amount of First-Priority Senior Secured Notes due 2028 (the “Notes”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The offering is subject to market conditions and other factors.The Company intends to use the net proceeds from the offering, together with borrowings under a new $2,300.0 million senior secured first lien term loan facility (expected to be upsized from the previously announced $2,200.0 million), to repay the borrowings outstanding under its existing term loan facility,...

SALT LAKE CITY, Feb. 02, 2021 (GLOBE NEWSWIRE) — To help more patients with rheumatoid arthritis (RA), Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today launched the new Vectra® Cardiovascular Risk assessment that can predict the risk for cardiovascular (CV) events in patients with RA. This new test result incorporates information on RA inflammation assessed by Vectra Score and three additional biomarkers, combined with traditional risk factors. Vectra is an advanced blood test that objectively measures inflammation caused by RA.“Due to inflammatory processes, patients with RA have approximately 50% greater risk for cardiovascular disease (CVD), the leading cause of mortality among patients with RA, which accounts for 30-40% of deaths.” said Elena Hitraya, M.D., Ph.D., rheumatologist...

CALGARY, Alberta, Feb. 02, 2021 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) announced today that it will participate in Cowen’s 42nd Annual Aerospace/Defense & Industrials Conference being held on February 9-11, 2021.Bill Tempany, Interim CEO, and Alana Forbes, CFO, will virtually present an overview of the company’s strategy and participate in a fireside chat on Tuesday, February 9, at 4:00 PM ET (2:00 PM MT). In addition, Mr. Tempany will also participate in a panel discussion titled, “Innovations in Aerospace: How New Technology is Improving Costs and Enabling Safer Flight,” on Wednesday, February 10, at 10:10 AM ET (8:10 AM MT).A live audio webcast of the Company’s presentation will be available at http://bit.ly/FLYHTcowen with a replay available for 90...

Not For Distribution to United States Newswire Services or For Dissemination in the United StatesTORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) — Bunker Hill Mining Corporation (the “Company”) (CSE: BNKR) announces an increase to the previously announced non-brokered equity private placement (the “Offering”) from 12,500,000 units of the Company (“Units”) to up to 18,750,000 Units at C$0.40 per Unit for potential gross proceeds of C$8.0 million.Each Unit consists of one common share of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each whole Warrant entitles the holder to acquire one Common Share at a price of C$0.60 per Common Share for a period of five years. The Units and securities underlying them will be subject to a customary four month and a day hold period in accordance with applicable Canadian...